BR Biopharma (NASDAQ:BRBI) Shares Up 0.5% – Here’s Why

BR Biopharma, Inc. (NASDAQ:BRBI)’s stock price was up 0.5% during trading on Friday . The company traded as high as $9.40 and last traded at $9.40. Approximately 1,520 shares were traded during mid-day trading, an increase of 287% from the average session volume of 393 shares. The stock had previously closed at $9.35.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised BR Biopharma from a “sell (e)” rating to a “sell (d-)” rating in a report on Thursday, June 4th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, BR Biopharma has a consensus rating of “Sell”.

BR Biopharma Price Performance

The company’s 50 day moving average price is $11.32.

BR Biopharma (NASDAQ:BRBI) last issued its quarterly earnings data on Tuesday, June 30th. The company reported $0.09 earnings per share for the quarter. The business had revenue of $25.13 million during the quarter.

BR Biopharma Cuts Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 4th. Shareholders of record on Monday, August 17th will be given a $0.1415 dividend. The ex-dividend date is Monday, August 17th. This represents a $0.57 annualized dividend and a yield of 6.0%.

Institutional Investors Weigh In On BR Biopharma

A hedge fund recently bought a new stake in BR Biopharma stock. Acuitas Investments LLC acquired a new position in BR Biopharma, Inc. (NASDAQ:BRBI) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 3,000 shares of the company’s stock, valued at approximately $45,000. BR Biopharma makes up 3.2% of Acuitas Investments LLC’s investment portfolio, making the stock its 7th largest position.

BR Biopharma Company Profile

BRBI BR Partners SA, through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners SA is based in S?o Paulo, Brazil.